 | Up a level |
Journal Article
Kuhr, K., Scheckel, B., Haque, M., Weigl, A., Monsef, I, Bohlius, J. and Skoetz, N. (2018). Intravenous versus oral versus no iron with or without erythropoiesisstimulating agents (ESA) for anaemic cancer patients: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 215 - 217. BASEL: KARGER. ISSN 2296-5262
Tesfamariam, Y., Jakob, T., Woeckel, A., Adams, A., Weigl, A., Monsef, I., Kuhr, K. and Skoetz, N. (2019). Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis. Crit. Rev. Oncol./Hematol., 137. S. 1 - 9. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461
Weigl, A., Koehler, N., Monsef, I., Bohlius, J., Becker, I., Kuhr, K. and Skoetz, N. (2017). INTRAVENOUS IRON VERSUS ORAL IRON VERSUS NO IRON WITH OR WITHOUT ERYTHROPOIESISSTIMULATING AGENTS FOR CANCER PATIENTS WITH ANAEMIA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Haematologica, 102. S. 334 - 335. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078